Metraipolis › archive › dc_4c74740bda59

PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42645640
DOI
10.1186/s43556-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-08T03:24:29.180Z
SHA-256 of the archived text
e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e
Stable URL of this page
https://metraipolis.com/documento/dc_4c74740bda59

How to cite

PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640 — Europe PMC (en), https://europepmc.org/article/MED/42645640 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c74740bda59 (Metraipolis archive dc_4c74740bda59, sha256 e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e)
BibTeX
@misc{dc4c74740bda59,
  title = {PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42645640},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c74740bda59; sha256 e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645640. Agents can read the archived copy with the MCP tool read_document.